For weeks, more than half a million Anthem Blue Cross enrollees who receive health care from the University of California were held in suspense.
Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization | Psychedelic Invest
VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the private clinical-stage pharmaceutical company developing psilocybin treatment for alcohol use disorder (AUD),